Health Systems Buy Stake In Key Drugmaker Exela; Sanofi Buys Kadmon
11 health systems and group purchaser Premier acquired a stake in Exela Pharma Sciences, a maker of proprietary and generic sterile injectables. Meanwhile, France's Sanofi paid $1.9 billion to buy Kadmon to boost its transplant business. Eliquis drug makers and drug naming are also in the news.
Premier And 11 Health Systems Buy Stake In Specialty Drugmaker
Eleven health systems and the group purchasing organization Premier have acquired a stake in a specialty pharmaceutical company to ensure steady supplies of key drugs. The group now owns a minority stake in Exela Holdings, the holding company of Exela Pharma Sciences, which makes proprietary and generic sterile injectable products. Financial terms were not disclosed. (Bannow, 9/8)
Sanofi Acquires Kadmon For $1.9 Billion, Adding Transplant Medicine Drug
French drug maker Sanofi said Wednesday that it will acquire Kadmon Pharmaceuticals for $1.9 billion, bolstering its transplant medicines business with a newly approved treatment for graft-versus-host disease. The all-cash transaction sees Kadmon shares worth $9.50 per share, or a 79% premium to Tuesday’s closing price. (Feuerstein, 9/8)
Bristol Myers, Pfizer Score Another Win In Their Eliquis Patent Defense, Protecting The Blockbuster Until 2028
As a top-selling drug worldwide, Pfizer and Bristol Myers Squibb’s Eliquis is a major target for generic players looking to steal branded sales. But with a new court win, the partners are set for many more years of exclusivity in the lucrative U.S. market. The U.S. Court of Appeals for the Federal Circuit has upheld a prior win for the companies covering two Eliquis patents—the drug’s composition of matter patent and a formulation patent. While the case is subject to another potential appeal, this appeals win sets the companies up to retain U.S. exclusivity until April 1, 2028. (Sagonowsky, 9/7)
KHN Quiz: Drug Or Not A Drug?
Face it: Drug names can be kooky. And Comirnaty — the brand-new brand name for the Pfizer-BioNTech covid vaccine — is a candidate for the kookiest. Who hasn’t stumbled over names of prescription drugs, even those you take daily, when put on the spot by a doctor or pharmacist? Take this tongue-in-cheek quiz to see how many brand-name drug names you can pick out from the decoys. (Byrne, 9/6)